Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

First preclinical data presented for AG-10 in ATTR cardiomyopathy

Nov. 24, 2017

Bayer Pharma identifies vasopressin receptor antagonists

Nov. 21, 2017

FDA approves new formulation and pediatric indication for Tekturna

Nov. 17, 2017

Bayer reports first-in-human data for BR-6819

Nov. 17, 2017

Bayer presents preclinical data on the cardiac effects of BAY-1142524 after myocardial infarction

Nov. 17, 2017

Amgen presents novel apelin receptor agonists

Nov. 17, 2017

Novel vasopressin V1A and V2 receptor antagonists developed at Bayer

Nov. 16, 2017

EMA grants Motrem access to PRIME scheme for septic shock

Nov. 15, 2017

PRD-125: a potent SOAT2 inhibitor ameliorates atherosclerosis in rabbits

Nov. 14, 2017

Phase II data presented for MEDI-6012 in patients with coronary heart disease

Nov. 14, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.